Table 2.
List of selected articles for analysis along with treatment focus, implemented themes, and tools recommended.
| First Author, Year | Country | Treatment Focus (N) | Implemented tool | Screening or Diagnostic Assessment Tool | Reference |
*Tool: Recommend or Not Recommend* |
Themes |
|---|---|---|---|---|---|---|---|
| Austin et al., (2023) | United States | Primary Care (10 clinics) | NIDA modified ASSIST | Screening | N/A- Qualitative Study | Not Recommended | NAD, NS, IC |
| Bunting et al., (2023) | United States | Primary Care (2000) | TAPS | Screening | Composite International Diagnostic Interview (CIDI) | Recommended | NAD, NS |
| Carter et al., (2022) | United States | Pharmacy (1523) | TAPS | Screening | WHO ASSIST | Recommended | NS |
| Di Paola et al., (2023) | United States | Psychiatry (150) | ROUDA | Diagnostic Assessment | MINI version 7 | Recommended | NAD, NS, IC |
| Edmond et al., (2022) | United States | multiple healthcare specialties (51 survey panelists) | DSM−5 | Diagnostic Assessment | N/A- Qualitative Study | Recommended | NAD, NS |
| Hasin et al., (2022) | United States | Pain Management and Inpatient Substance Treatment Facilities (606) | PRISM−5-OP, pain-adjusted POUD | Diagnostic Assessment | Interview assessing DSM−5 POUD | Recommended | NS |
| Kopak et al., (2024) | United States | Healthcare for Incarcerated Individuals (717) | UNCOPE | Screening | Comprehensive Addiction and Psychological Evaluation−5 (CAAPE) structured interview assessing DSM−5 criteria |
Recommended | MW |
| Kufeld et al., (2024) | Germany | Primary Care/Pain Management (14 telephone interviews) | DSM−5 Interview | Diagnostic Assessment | N/A- Qualitative Study | Not Recommended | NAD, NS |
| Lam et al., (2023) | Canada | Primary Care (6 participants) | Routine Opioid Outcome Monitoring (ROOM) Tool | Screening | N/A- Qualitative Study | Recommended | MW |
| Laporte et al., (2022) | France | Primary Care (160) | Prescription Opioid Misuse Index (POMI) | Screening | DSM−5 Questionnaire | Not Recommended | NAD, NS, IC, MW |
| Mallery Lankford, et al. (2022) | United States | Rheumatology (318) | Current Opioid Misuse Measure (COMM)- modified to COMM−11 PWDA | Screening | DSM−5 OUD Screener | Recommended | NAD, NS, IC |
| Nielsen et al., (2020) | Australia | Primary Care (1134) | OWLS | Screening | Modified CIDI assessing ICD−10, ICD−11 and DSM−5 | Recommended | NAD, NS, IC, MW |
| Picco et al., (2020a) | Australia | Primary Care (324) | OWLS | Screening | CIDI DSM−5 questions in an online module | Recommended | NS, IC |
| Picco et al., (2020b) | Australia | Primary Care (324) | Computer-Administered Routine Opioid Outcome Monitoring (ROOM) Tool - OWLS | Screening | CIDI DSM−5 questions in an online module | Recommended | NC, IC |
| Punches et al., (2024) | United States | Emergency Department (1305) | Adapted DSM−5 checklist and WHO ASSIST | Screening | Comparison study | Recommended | NS, IC |
| Staton et al., (2024) | United States | Healthcare for Incarcerated Individuals (200) | (NIDA Modified ASSIST) NM-ASSIST, DSM−5 Checklist | Screening | High risk drug use indicators | Recommended | NAD, MW |
| Sullivan et al., (2020) | United States | Inpatient Psychiatry (60) | DSM−5 level 2 | Screening | chart abstracted toxicology screens | Recommended | MW |
| Williams et al., (2024) | United States | Primary Care (2007) | Substance Use Symptom Checklist modified from 11 DSM−5 SUD criteria | Screening | Documentation of OUD diagnosis, treatment or long term opioid therapy | Recommended | NAD |
| Wilson et al., (2020) | United States | Emergency Department (154) | COMM | Screening | documentation of concerning drug behavior | Not Recommended | MW |
NAD: OUD diagnosis not always documented; NS: One tool not sufficient; IC: Inconsistent completion of tool; MW: OUD symptoms documented in multiple ways
⁎
For quantitative articles, the implemented tool was identified as recommended if it was consistent or provided better results than the reference. For qualitative articles, the recommendation is based on the authors’ conclusions, not diagnostic performance.